Table 2.

Adverse events within 28 d after vaccination.

	6–35 mo		3–17 y		18–60 y		≥ 61 y
	(N = 150)		(N = 150)		(N = 151)		(N = 151)
Event	n/M	%	n/M	%	n/M	%	n/M	%
Immediate unsolicited AE	2/150	1.3	0/150	0.0	0/151	0.0	0/151	0.0
Vaccine-related	2/150	1.3	0/150	0.0	0/151	0.0	0/151	0.0
Solicited reaction	70/141	49.6	72/148	48.6	35/150	23.3	24/151	15.9
Solicited injection-site reaction	33/140	23.6	53/148	35.8	26/150	17.3	13/151	8.6
Solicited systemic reaction	60/140	42.9	39/148	26.4	16/150	10.7	14/151	9.3
Unsolicited AE	62/150	41.3	12/150	8.0	4/151	2.6	5/151	3.3
Vaccine-related	11/150	7.3	0/150	0.0	0/151	0.0	3/151	2.0
Non-serious	62/150	41.3	11/150	7.3	4/151	2.6	4/151	2.6
Non-serious vaccine-related	11/150	7.3	0/150	0.0	0/151	0.0	3/151	2.0
Injection-site non-serious vaccine related	0/150	0.0	0/150	0.0	0/151	0.0	0/151	0.0
AE leading to study discontinuation	14/150	9.3	0/150	0.0	0/151	0.0	0/151	0.0
SAE	1/150	0.7	1/150	0.7	0/151	0.0	1/151	0.7
Vaccine-related	0/150	0.0	0/150	0.0	0/151	0.0	0/151	0.0
Death	0/150	0.0	0/150	0.0	0/151	0.0	0/151	0.0

Abbreviations: AE, adverse event; SAE, serious adverse event